Menu

HomeHow it worksContact UsContact Us

Human Milk Oligosaccharides in Exercise Nutrition: Structure-Specific Evidence, Human Efficacy, and Translational Bottlenecks

Qiao C, Guo S, Yang S, Yang C, Wang Y. · Preprints.org · 2026

This review examined whether human milk oligosaccharides (HMOs)—carbohydrates found in breast milk—could improve exercise performance and athletic outcomes in adults. While some HMOs showed biological activity and changed gut bacteria in studies, direct evidence of exercise benefits in humans was sparse and inconsistent, with no study demonstrating a complete chain from consuming HMOs to actual improvements in muscle function or performance.
Abstract (source)

Background: /

Objectives: Human milk oligosaccharides (HMOs) are structurally diverse bioactive carbohydrates being investigated beyond early-life nutrition. General gut–muscle and short-chain-fatty-acid frameworks are already well described; the unresolved issue is whether structure-defined HMOs produce reproducible exercise benefits in humans and where translation from model-based mechanisms fails.

Methods: This critical translational review systematically searched PubMed/MEDLINE, Embase, Web of Science Core Collection, Scopus, and SPORTDiscus. Evidence was assigned non-exclusively to Layer A (direct exercise evidence), Layer B (exercise-relevant mechanisms), or Layer C (adult translational evidence). We separately evaluated HMO structure, prespecified human efficacy outcomes, within-model causal support, and distance from healthy human exercise.

Results: The five databases yielded 4,787 records; 40 reports representing 38 independent studies were included. Several HMOs were tolerated at the doses and durations tested and produced structure-, dose-, and host-dependent microbial responses; limited systemic exposure was documented for selected structures. Some intestinal and disease-model pathways had perturbation, knockout, transfer, or rescue support. However, direct human exercise evidence was sparse and inconsistent: primary or overall interaction tests were generally null, whereas favorable

Findings: were mainly secondary, interim, within-group, or exploratory. No study established the complete sequence from oral exposure to target engagement, healthy skeletal-muscle adaptation, and improved performance.

Conclusions: Current evidence supports biological activity and testability of selected HMOs, but not an HMO class effect, a confirmed ergogenic mechanism, or a recommendation for exercise-performance use. Translation is constrained by four unresolved links: structure to exposure, exposure to target engagement, target engagement to muscle phenotype, and muscle phenotype to functional benefit.

Read the original →